EP2252301
Notkun á úliprístal við meðferð á bandvöðvaæxli í legi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.1.2009EP published:
11.12.2013EP application number:
09706347.3
EP translation filed:
12.2.2014Grant published:
15.3.2014EPO information:
European Patent Register
Max expiry date:
27.1.2029Expiry date:
27.1.2021
Title:
USE OF ULIPRISTAL FOR TREATING UTERINE FIBROIDS
Timeline
Today
28.1.2009EP application
11.12.2013EP Publication
12.2.2014Translation submitted
15.3.2014Registration published
27.1.2021Expires
Owner
Name:
The U.S.A. as represented by the Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, MSC 7660, 20892-7660, Bethesda, MD, US
Name:
Laboratoire HRA PharmaAddress:
15, rue Béranger, 75003, Paris, FR
Inventor
Name:
GAINER, ErinAddress:
Paris, FR
Name:
NIEMAN, LynnetteAddress:
Bethesda, MD, US
Name:
ULMANN, AndréAddress:
Paris, FR
Name:
BLITHE, DianaAddress:
Silver Spring, MD, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
21610Date:
29.1.2008Country:
US
Classification
Categories:
A61K 31/57, A61P 5/36, A61P 15/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 12.2.2014
Expires: 27.1.2015
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 15.1.2015
Expires: 27.1.2016
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 21.1.2016
Expires: 27.1.2017
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 20.1.2017
Expires: 27.1.2018
Payer: Tego ehf.
Number: 10
Paid: 25.1.2018
Expires: 27.1.2019
Payer: Tego ehf.
Number: 11
Paid: 30.1.2019
Expires: 27.1.2020
Payer: Tego ehf.
Number: 12
Paid: 27.1.2020
Expires: 27.1.2021
Payer: Tego ehf.